Download PDF
Geburtshilfe Frauenheilkd 2000; 60(12): 594-603
DOI: 10.1055/s-2000-9543
Übersicht

Georg Thieme Verlag Stuttgart · New York

Die Bedeutung der Strahlentherapie in der Behandlung des Mammakarzinoms

Radiotherapy in Breast CancerA. Buchali1 , V. Budach2
  • 1 Klinik für Strahlentherapie, Ruppiner Kliniken GmbH, Neuruppin
  • 2 Klinik für Strahlentherapie, Universitätsklinikum Charité, Berlin
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Strahlentherapie zählt zu einer der drei Säulen in der primären Behandlung von Patientinnen mit einem Mammakarzinom. Für Patientinnen mit einem DCIS ermöglicht die adjuvante Nachbestrahlung nach kompletter Resektion ein brusterhaltendes Vorgehen mit einer deutlichen Verbesserung des ereignisfreien Überlebens. Nach brusterhaltender Operation eines lokal begrenzten invasiven Mammakarzinoms ist die Strahlentherapie obligat und senkt die Rate von Lokalrezidiven ohne das Gesamtüberleben zu beeinflussen. Hochrisiko-Patientinnen profitieren von einer lokoregionären Strahlentherapie, bei einem Einsatz moderner Bestrahlungstechniken ist die resultierende kardiale Morbidität und Mortalität nicht mehr erhöht. Subgruppen, bei denen auf eine Strahlentherapie nach brusterhaltender Operation verzichtet werden kann, sind anhand der Datenlage nicht klar zu definieren. Die optimale Sequenz der adjuvanten Strahlentherapie und Chemotherapie ist derzeit unklar, ein später Einsatz der Strahlentherapie geht mit einer Erhöhung von Lokalrezidiven und ein später Einsatz der Chemotherapie mit einem höheren Fernmetastasierungsrisiko einher.

Summary

Radiotherapy is one of the three modalities used in the primary treatment of breast cancer. For patients with ductal carcinoma in situ after complete resection, adjuvant radiotherapy permits breast-sparing treatment and increases the event-free survival. Radiotherapy is mandatory after breast-sparing excision of localized invasive carcinomas and reduces the rate of local recurrence, albeit without affecting overall survival. Currently the data do not permit identification of subgroups of patients with invasive breast cancer after breast-sparing surgery in whom adjuvant radiotherapy could be declined. High-risk patients benefit from locoregional radiotherapy. Modern radiation techniques are no longer associated with cardiac morbidity and mortality. The optimal sequence of adjuvant radiotherapy and chemotherapy is unclear. Delayed radiotherapy is associated with an increased risk of local recurrence whereas delayed chemotherapy is associated with an increased risk of distant recurrence.

Literatur

  • 1 Amichetti M, Caffo O, Richetti A, Zini G, Rigon A, Antonello M, Arcicasa M, Coghetto F, Valdagni R, Maluta S, Di-Marco A. Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy.  Eur J Cancer. 1997;  33 1559-1565
    CrossrefPubMedGoogle Scholar
  • 2 Arriagada R, Rutquist L E, Mattsson A, Kramar A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination.  J Clin Oncol. 1995;  13 2869-2878
    PubMedGoogle Scholar
  • 3 Bahena J, Labastida-Almendaro S, Ayala-Hernandez J R, Fernandez-Orozco A. Impact of the interval between surgery and radiotherapy in the initial phases of breast cancer in patients who did not receive systemic adjuvant therapy.  Ginecol Obstet Mex. 1998;  66 87-91
    PubMedGoogle Scholar
  • 4 Bartelink H. Radiotherapy in the management of early breast cancer: a review.  Eur J Cancer Clin Oncol. 1988;  24 77-82
    CrossrefPubMedGoogle Scholar
  • 5 Bartelink H, Borger J H, vanDongen J A, Peterse J L. The impact of tumor size and histology on local control after breast-conserving therapy.  Radiother Oncol. 1988;  11 297-303
    CrossrefPubMedGoogle Scholar
  • 6 Bedwinek J. Breast conserving surgery and irradiation: the importance of demarcating the excision cavity with surgical clips.  Int J Radiat Oncol Biol Phys. 1993;  26 675-679
    PubMedGoogle Scholar
  • 7 Blomqvist C, Tiusanen K, Elomaa I, Rissanen P, Hietanen T, Heinonen E, Grohn P. The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial.  Br J Cancer. 1992;  66 1171-1176
    PubMedGoogle Scholar
  • 8 Brufman G, Sulkes A, Biran S. Adjuvant chemotherapy with and without radiotherapy in stage II breast cancer.  Biomed Pharmacother. 1988;  42 351-355
    PubMedGoogle Scholar
  • 9 Budach V, Sauer R. Postoperative radiotherapy in high risk patients with breast cancer and adjuvant chemotherapy.  Strahlenther Onkol. 1998;  174 106-107
    PubMedGoogle Scholar
  • 10 Bulman A S, Lindley R P, Parsons P, Ellis H. Pathological features of invasive breast cancer associated with a high risk of local recurrence after tumour excision and radical radiotherapy.  Ann R Coll Surg Engl. 1988;  70 289-292
    PubMedGoogle Scholar
  • 11 Cabanes P A, Salmon R J, Vilcoq J R, Durand J C, Fourquet A, Gautier C, Asselain B. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie.  Lancet. 1992;  339 (8804) 1245-1248
    CrossrefPubMedGoogle Scholar
  • 12 Clark R M, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson R H, Mahoney L J. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.  J Natl Cancer Inst. 1996;  88 (22) 1659-1664
    CrossrefPubMedGoogle Scholar
  • 13 Cuzick J, Stewart H, Peto R, Baum M, Fisher B, Host H, Lythgoe J P, Ribeiro G, Scheurlen H, Wallgren A. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer.  Cancer Treat Rep. 1987;  71 15-29
    PubMedGoogle Scholar
  • 14 Dewar J A, Arriagada R, Benhamou S, Benhamou E, Bretel J J, Pellae-Cosset B, Marin J L, Petit J Y, Contesso G, Sarrazin D. Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970 - 1982). IGR Breast Cancer Group.  Cancer. 1995;  76 2260-2265
    PubMedGoogle Scholar
  • 15 Donegan W L, Perez-Mesa C M, Watson F R. A biostatistical study of locally recurrent breast carcinoma.  Surg Gynecol Obstet. 1966;  122 529-540
    PubMedGoogle Scholar
  • 16 Dunst J. Radiotherapy following quadrantectomy in breast carcinoma.  Strahlenther Onkol. 1993;  169 626-627
    PubMedGoogle Scholar
  • 17 Early Breast Cancer Trialists' Collaborative Group . Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group.  N Engl J Med. 1995;  333 1444-1455
    CrossrefPubMedGoogle Scholar
  • 18 Early Breast Cancer Trialists' Collaborative Group . Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials.  Lancet. 2000;  355 1757-1770
    CrossrefPubMedGoogle Scholar
  • 19 Early Breast Cancer Trialists' Collaborative Group . Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.  Lancet. 1998;  352 (9132) 930-942
    CrossrefPubMedGoogle Scholar
  • 20 Epstein A H, Connolly J L, Gelman R, Schnitt S J, Silver B, Boyages J, Rose M A, Recht A, Harris J R. The predictors of distant relapse following conservative surgery and radiotherapy for early breast cancer are similar to those following mastectomy.  Int J Radiat Oncol Biol Phys. 1989;  17 755-760
    PubMedGoogle Scholar
  • 21 Fein D A, Fowble B L, Hanlon A L, Hoffman J P, Sigurdson E R, Eisenberg B L. Does the placement of surgical clips within the excision cavity influence local control for patients treated with breast-conserving surgery and irradiation.  Int J Radiat Oncol Biol Phys. 1996;  34 1009-1017
    CrossrefPubMedGoogle Scholar
  • 22 Fisher B, Anderson S, Redmond C K, Wolmark N, Wickerham D L, Cronin W M. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer.  N Engl J Med. 1995;  333 1456-1461
    CrossrefPubMedGoogle Scholar
  • 23 Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, Wolmark N, Wickerham L, Deutsch M, Ore L, Mamounas E, Poller W, Kavanah M. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.  N Engl J Med. 1993;  328 1581-1586
    CrossrefPubMedGoogle Scholar
  • 24 Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher E R, Wickerham D L, Deutsch M, Margolese R, Dimitrov N, Kavanah M. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.  J Clin Oncol. 1998;  16 441-452
    PubMedGoogle Scholar
  • 25 Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher E, Deutsch M, Caplan R, Pilch Y, et-al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.  N Engl J Med. 1989;  320 822-828
    CrossrefPubMedGoogle Scholar
  • 26 Fisher B, Wickerham L, Deutsch M, Anderson S, Redmond C, Fisher E. Breast tumor recurrence following lumpectomy with and without breast irradition: An overview of recent NSABP findings.  Sem Surg Oncol. 1992;  8 153-160
    PubMedGoogle Scholar
  • 27 Forrest A P, Stewart H J, Everington D, Prescott R J, McArdle C S, Harnett A N, Smith D C, George W D. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group.  Lancet. 1996;  348 (9029) 708-713
    CrossrefPubMedGoogle Scholar
  • 28 Fortin A, Larochelle M, Laverdiere J, Lavertu S, Tremblay D. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy.  J Clin Oncol. 1999;  17 101-109
    PubMedGoogle Scholar
  • 29 Fowble B. The relationship between local relapse and distant metastases revisited.  Int J Radiat Oncol Biol Phys. 1994;  30 237-239
    PubMedGoogle Scholar
  • 30 Fowble B, Gray R, Gilchrist K, Goodman R L, Taylor S, Tormey D C. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy.  J Clin Oncol. 1988;  6 1107-1117
    PubMedGoogle Scholar
  • 31 Handley R S. A surgeon's view of the spread of breast cancer.  Cancer. 1969;  24 1231-1234
    PubMedGoogle Scholar
  • 32 Halverson K J, Perez C A, Taylor M E, Myerson R, Philpott G, Simpson J R, Tucker G, Rush C. Age as a prognostic factor for breast and regional nodal recurrence following breast conserving surgery and irradiation in stage I and II breast cancer.  Int J Radiat Oncol Biol Phys. 1993;  27 1045-1050
    PubMedGoogle Scholar
  • 33 Hartsell W F, Recine D C, Griem K L, Murthy A K. Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence.  Cancer. 1995;  76 2497-2503
    PubMedGoogle Scholar
  • 34 Hojris I, Overgaard M, Christensen J J, Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82 b and 82 c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group.  Lancet. 1999;  354 (9188) 1425-1430
    CrossrefPubMedGoogle Scholar
  • 35 Host H, Brennhovd I O. The effect of postoperative radiotherapy in breast cancer.  Int J Radiat Oncol Biol Phys. 1977;  2 1061-1067
    PubMedGoogle Scholar
  • 36 Jacobson J A, Danforth D N, Cowan K H, d'Angelo T, Steinberg S M, Pierce L, Lippman M E, Lichter A S, Glatstein E, Okunieff P. Ten year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer.  N Engl J Med. 1995;  332 907-911
    CrossrefPubMedGoogle Scholar
  • 37 Jansson T, Inganas M, Sjogren S, Norberg T, Lindgren A, Holmberg L, Bergh J. p53 status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings.  J Clin Oncol. 1995;  13 2745-2751
    PubMedGoogle Scholar
  • 38 Julien J P, Bijker N, Fentiman I S, Peterse J L, Delledonne V, Rouanet P, Avril A, Sylvester R, Mignolet F, Bartelink H, Dongen J A. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10, 853.  Lancet. 2000;  355 528-533
    CrossrefPubMedGoogle Scholar
  • 39 Kemperman H, Borger J, Hart A, Peterse H, Bartelink H, van-Dongen J. Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence.  Eur J Cancer. 1995;  31 A 690-698
    CrossrefPubMedGoogle Scholar
  • 40 Krawczyk J J, Engel B. The importance of surgical clips for adequate tangential beam planning in breast conserving surgery and irradiation.  Int J Radiat Oncol Biol Phys. 1999;  43 347-50
    CrossrefPubMedGoogle Scholar
  • 41 Kurtz J M, Amalric R, Brandone H, Ayme Y, Jacquemier J, Pietra J C, Hans D, Pollet J F, Bressac C, Spitalier J M. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis.  Cancer. 1989;  63 1912-1917
    CrossrefPubMedGoogle Scholar
  • 42 Kurtz J M, Amalric R, Brandone H, Ayme Y, Spitalier J M. Results of wide excision for mammary recurrence after breast-conserving therapy.  Cancer. 1988;  61 1969-1972
    PubMedGoogle Scholar
  • 43 Kurtz J M, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, Bressac C, Spitalier J M. Why are local recurrences after breast-conserving therapy more frequent in younger patients?.  J Clin Oncol. 1990;  8 591-598
    PubMedGoogle Scholar
  • 44 Lacour J, Bucalossi P, Cacers E, Jacobelli G, Koszarowski T, Le M, Rumeau-Rouquette C, Veronesi U. Radical mastectomy versus radical mastectomy plus internal mammary dissection.  Cancer. 1976;  37 206-214
    PubMedGoogle Scholar
  • 45 Leonard C E, Wood M E, Zhen B, Rankin J, Waitz D A, Norton L, Howell K, Sedlacek S. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?.  J Clin Oncol. 1995;  13 2906-2915
    PubMedGoogle Scholar
  • 46 Liljegren G, Holmberg L, Adami H O, Westman G, Graffman S, Bergh J. Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group.  J Natl Cancer Inst. 1994;  86 717-722
    CrossrefPubMedGoogle Scholar
  • 47 Liljegren G, Lindgren A, Bergh J, Nordgren H, Tabar L, Holmberg L. Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy.  Ann Oncol. 1997;  8 235-241
    CrossrefPubMedGoogle Scholar
  • 48 Locker A P, Ellis I O, Morgan D A, Elston C W, Mitchell A, Blamey R W. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer.  Br J Surg. 1989;  76 890-894
    CrossrefPubMedGoogle Scholar
  • 49 Machtay M, Lanciano R, Hoffmann J, Hanks G. Inaccuracies in using the lumpectomy scar for planning electron boosts in primary breast carcinoma.  Int J Radiat Oncol Biol Phys. 1994;  30 43-48
    PubMedGoogle Scholar
  • 50 Nemoto T, Patel J K, Rosner D, Dao T L, Schuh M, Penetrante R. Factors affecting recurrence in lumpectomy without irradiation for breast cancer.  Cancer. 1991;  67 2079-2082
    PubMedGoogle Scholar
  • 51 Nixon A J, Manola J, Gelman R, Bornstein B, Abner A, Hetelekidis S, Recht A, Harris J R. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques.  J Clin Oncol. 1998;  16 1374-1379
    PubMedGoogle Scholar
  • 52 Nixon A J, Recht A, Neuberg D, Connolly J L, Schnitt S, Abner A, Harris J R. The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy.  Int J Radiat Oncol Biol Phys. 1994;  30 (1) 17-21
    PubMedGoogle Scholar
  • 53 Osteen R T, Smith B L. Results of conservative surgery and radiation therapy for breast cancer.  Surg Clin North Am. 1990;  70 1005-1021
    PubMedGoogle Scholar
  • 54 Overgaard M, Hansen P S, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg C C, Mouridsen H T, Jensen M B, Zedeler K. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82 b Trial.  N Engl J Med. 1997;  337 949-955
    CrossrefPubMedGoogle Scholar
  • 55 Overgaard M, Jensen M B, Overgaard J, Hansen P S, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg C C, Rasmussen B B, Blichert-Toft M, Mouridsen H T. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82 c randomised trial.  Lancet. 1999;  353 (9165) 1641-1648
    CrossrefPubMedGoogle Scholar
  • 56 Pierce L J, Lichter A S. Defining the role of post-mastectomy radiotherapy: The new evidence.  Oncology. 1996;  10 991-1011
    PubMedGoogle Scholar
  • 57 Ragaz J, Jackson S M, Le N, Plenderleith I H, Spinelli J J, Basco V E, Wilson K S, Knowling M A, Coppin C M, Paradis M, Coldman A J, Olivotto I A. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.  N Engl J Med. 1997;  337 956-962
    CrossrefPubMedGoogle Scholar
  • 58 Ragaz J, Jackson S M, Manji M, Wilson K S, Olivotto I A, Coldman A J, Spinelli J J. Postmastectomy radiation (RT) outcome in node (N) positive breast cancer patients among N1 - 3 versus N4 + subset: Impact of extracapsular spread (ES). Update of the British Columbia Randomized Trial. Proc ASCO 18: 73 a. 
    Google Scholar
  • 59 Rauschecker H F, Sauerbrei W, Gatzemeier W, Sauer R, Schauer A, Schmoor C, Schumacher M. Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG).  Eur J Cancer. 1998;  34 315-323
    CrossrefPubMedGoogle Scholar
  • 60 Rayter Z, Gazet J C, Ford H T, Easton D F, Coombes R C. Comparison of conservative surgery and radiotherapy with mastectomy in the treatment of early breast cancer.  Eur J Surg Oncol. 1990;  16 486-492
    PubMedGoogle Scholar
  • 61 Recht A. Selection of patients with early stage invasive breast cancer for treatment with conservative surgery and radiation therapy.  Semin Oncol. 1996;  23 (Suppl 2) 19-30
    PubMedGoogle Scholar
  • 62 Recht A, Come S E, Gelman R S, Goldstein M, Tishler S, Gore S M, Abner A L, Vicini F A, Silver B, Connolly J L. et al . Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome.  J Clin Oncol. 1991;  9 1662-1667
    PubMedGoogle Scholar
  • 63 Recht A, Come S E, Henderson I C, Gelman R S, Silver B, Hayes D F, Shulman L N, Harris J R. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer.  N Engl J Med. 1996;  334 1356-1361
    CrossrefPubMedGoogle Scholar
  • 64 Recht A, Pierce S M, Abner A, Vicini F, Osteen R T, Love S M, Silver B, Harris J R. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma.  J Clin Oncol. 1991;  9 988-996
    PubMedGoogle Scholar
  • 65 O'Rourke S, Galea M H, Morgan D, Euhus D, Pinder S, Ellis I O, Elston C W, Blamey R W. Local recurrence after simple mastectomy.  Br J Surg. 1994;  81 386-389
    PubMedGoogle Scholar
  • 66 Rutqvist L E, Cedermark B, Glas U, Johansson H, Rotstein S, Skoog L, Somell A, Theve T, Askergren J, Friberg S. et al . Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials.  Int J Radiat Oncol Biol Phys. 1989;  16 629-639
    PubMedGoogle Scholar
  • 67 Rutqvist L E, Liedberg A, Hammar N, Dalberg K. Myocardial infarction among women with early-stage breast cancer treated with conservative surgery and breast irradiation.  Int J Radiat Oncol Biol Phys. 1998;  40 359-363
    CrossrefPubMedGoogle Scholar
  • 68 Sauer R, Schauer A, Rauschecker H F, Schumacher M, Gatzemeier W, Sauerbrei W, Dunst J, Seegenschmiedt M H, Marx D. Breast preservation versus mastectomy in early breast cancer - 1991 update of the GBSG 1 - protocol and prognostic factors. The German Breast Cancer Study Group.  Strahlenther Onkol. 1992;  168 191-202
    PubMedGoogle Scholar
  • 69 Schnitt S J, Abner A, Gelman R, Connolly J S, Recht A, Duda R B, Eberlein T J, Mayzel K, Silver B, Harris J R. The relationship between microscopic margins of resection and the risk od local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy.  Cancer. 1994;  74 1746-1751
    PubMedGoogle Scholar
  • 70 Silverstein M J, Lagios M D, Craig P H, Waisman J R, Lewinsky B S, Colburn W J, Poller D N. A prognostic index for ductal carcinoma in situ of the breast.  Cancer. 1996;  77 2267-2274
    CrossrefPubMedGoogle Scholar
  • 71 Silverstein M J, Lagios M D. Benefits of irradiation for DCIS: a pyrrhic victory.  Lancet. 2000;  355 510-511
    CrossrefPubMedGoogle Scholar
  • 72 Slotman B J, Meyer O W, Njo K H, Karim A B. Radiotherapy following breast-conserving surgery: more local recurrences after longer delay.  Ned Tijdschr Geneeskd. 1995;  139 (47) 2427-2432
    PubMedGoogle Scholar
  • 73 Solin L J, Fowble B L, Schultz D J, Goodman R L. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer.  Int J Radiat Oncol Biol Phys. 1991;  21 279-287
    PubMedGoogle Scholar
  • 74 Solin L J, Kurtz J, Fourquet A, Amalric R, Recht A, Bornstein B A, Kuske R, Taylor M, Barrett W, Fowble B, Haffty B, Schultz D J, Yeh I T, McCormick B, McNeese M. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.  J Clin Oncol. 1996;  14 754-763
    PubMedGoogle Scholar
  • 75 Solin L J, Recht A, Fourquet A, Kurtz J, Kuske R, McNeese M, McCormick B, Cross M A, Schultz D J, Bornstein B A. et al . Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast.  Cancer. 1991;  68 2337-2344
    PubMedGoogle Scholar
  • 76 Stadler B, Staffen A, Strasser K, Wrba F, Stanek C. Prognostic factors for local recurrence in patients with limited surgery and irradiation of breast cancer.  Strahlenther Onkol. 1990;  166 453-456
    PubMedGoogle Scholar
  • 77 Stal O, Sullivan S, Wingren S, Skoog L, Rutqvist L E, Carstensen J M, Nordenskjold B. c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer.  Eur J Cancer. 1995;  31 A (13 - 14) 2185-2190
    CrossrefPubMedGoogle Scholar
  • 78 Stefanik D, Goldberg R, Byrne P, Smith F, Ueno W, Smith L, Bachenheimer L, Beiser C, Dritschilo A. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer.  J Clin Oncol. 1985;  3 660-665
    PubMedGoogle Scholar
  • 79 Stotter A T, McNeese M, Oswald M J, Ames F C, Romsdahl M M. The role of limited surgery with irradiation in primary treatment of ductal in situ breast cancer.  Int J Radiat Oncol Biol Phys. 1990;  18 283-287
    PubMedGoogle Scholar
  • 80 Trovo M G, Gigante M, Roncadin M, Arcicasa M, Bortolus R. Timing of radiotherapy in the treatment of breast carcinoma. Review of the literature.  Ann Ital Chir. 1999;  70 (3) 371-376
    PubMedGoogle Scholar
  • 81 Veronesi U, Marubini E, Del-Vecchio M, Manzari A, Andreola S, Greco M, Luini A, Merson M, Saccozzi R, Rilke F. et al . Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.  J Natl Cancer Inst. 1995;  87 19-27
    CrossrefPubMedGoogle Scholar
  • 82 Veronesi U, Luini A, Del-Vecchio M, Greco M, Galimberti V, Merson M, Rilke F, Sacchini V, Saccozzi R, Savio T. et al . Radiotherapy after breast-preserving surgery in women with localized cancer of the breast.  N Engl J Med. 1993;  328 1587-1591
    CrossrefPubMedGoogle Scholar
  • 83 Veronesi U, Valagussa P. Inefficiacy of internal mammary nodes dissection in breast cancer surgery.  Cancer. 1981;  47 170-175
    PubMedGoogle Scholar
  • 84 Vujovic O, Perera F, Dar A R, Stitt L, Yu E, Voruganti S M, Truong P T. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence?.  Int J Radiat Oncol Biol Phys. 1998;  40 869-874
    CrossrefPubMedGoogle Scholar
  • 85 Wallgren A, Arner O, Bergstrom J, Blomstedt B, Granberg P O, Raf L, Silfversward C, Einhorn J. Radiation therapy in operable breast cancer: results from the Stockholm trial on adjuvant radiotherapy.  Int J Radiat Oncol Biol Phys. 1986;  12 533-537
    PubMedGoogle Scholar
  • 86 Wallgren A, Bernier J, Gelber R D, Goldhirsch A, Roncadin M, Joseph D, Castiglione-Gertsch M. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.  Int J Radiat Oncol Biol Phys. 1996;  35 649-659
    CrossrefPubMedGoogle Scholar
  • 87 Whelan T, Clark R, Roberts R, Levine M, Foster G. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group.  Int J Radiat Oncol Biol Phys. 1994;  30 11-16
    CrossrefPubMedGoogle Scholar
  • 88 Whelan T J, Lada B M, Laukkanen E, Perera F E, Shelley W E, Levine M N. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.  Cancer Prev Control. 1997;  1 228-240
    PubMedGoogle Scholar

Dr. med. A. Buchali

Klinik für Strahlentherapie Ruppiner Kliniken GmbH

Fehrbelliner Straße 38

16816 Neuruppin

      >